S 1131 · 118th Congress · Health

Drug Price Transparency Act of 2023

Introduced 2023-03-30· Sponsored by Sen. Braun, Mike [R-IN]· Senate

Bill Progress

✓
Introduced
2
Committee
3
Senate Vote
4
House
5
Enacted
Latest: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.(2023-03-30)

Plain Language Summary

[AI summary unavailable — showing source text] Drug Price Transparency Act of 202 3 This bill provides statutory authority for the limitation on which type of prescription drug rebates are exempt from federal anti-kickback laws. Specifically, a rebate from a drug manufacturer to a health insurer or pharmacy benefit manager is exempt only if the rebate (1) is disclosed to the consumer at the point of sale, or (2) is a flat fee paid for pharmacy benefit management services.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (1)

1 Republican
Sen. Hyde-Smith, Cindy [R-MS]MS